A freeze-dried pellet, each dose containing live attenuated Bovine Respiratory Syncytial Virus (BRSV), strain RB94, minimum 105.5 CCID50 supplied with a vial of sterile diluent (water for injection and sodium chloride) for reconstitution.

For the active immunisation of calves to reduce infections and clinical signs associated with BRSV.

Onset of immunity occurs by 7 days after vaccination, as demonstrated serologically.

Studies have shown a duration of immunity of at least 4 months.

Reconstitute each 5 dose vial with 10 ml sterile diluent. Immediately give 2 ml reconstituted vaccine intramuscularly.

As far as possible take reasonable aseptic precautions in reconstituting and withdrawing vaccine. Reconstituted vaccine should be used immediately. Do not use chemically sterilised syringes or needles, as these will affect the effectiveness of the vaccine.

Give 2 doses three to four weeks apart.

Give 2 doses with a 3 to 4 week interval, with a third dose at 4 months of age. The third dose is required due to the possible interference from high titres of maternally derived antibodies during the first few months of life. An interval of at least 14 days should be observed between the second and third injection.

Ideally animals should be vaccinated during the autumn or at housing prior to the period of greatest risk. Maximum protection occurs when the whole herd is vaccinated.

Do not use in unhealthy animals.

Anaphylactic reactions may occasionally occur. Where necessary, appropriate antihistaminic treatment should be instituted.

No reactions other than those listed above have been observed following administration of a ten times overdose with Rispoval RS.

Zero days.

In case of accidental self-injection, wash the area immediately with water. If symptoms develop, seek medical attention showing a copy of the package insert.

Store between +2°C and +8°C. Do not freeze.

No information is available on the safety and efficacy from the concurrent use of this vaccine with any other except Rispoval™ Pasteurella (inactivated Mannheimia (Pasteurella) haemolytica vaccine), Tracherine™ (live infectious bovine rhinotracheitis vaccine) and Imuresp™ RP (live infectious bovine rhinotracheitis and Parainfluenza type 3 vaccine). A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Do not mix with any other veterinary medicinal product except the diluent provided.

Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved by the competent authorities.

Packs containing a 5 dose vial supplied with a vial containing 10 ml of sterile diluent.

Rispoval RS can be used during pregnancy.